随着今年辉瑞收购惠氏以及默克收购先灵葆雅,期待已久的制药行业巨额交易回归了。
This year the pharmaceutical mega-deal has made a long-awaited return, with Pfizer bidding for Wyeth and Merck for Schering-Plough.
根据这一调查,在这一时段经理们最乐于接受雇员的要求。该调查是制药业巨头、避孕药生产商拜耳先灵医药公司委托开展的。
This is the time that managers are likely to be most receptive to employees' demands, according to the poll carried out for pharmaceuticals giant and contraceptives manufacturer Bayer Schering pharma.
默克制药(MRK)收购Schering-Plough(先灵葆雅),希望到2013年在新兴市场的由目前的18%上升至25%。
Since it purchased Schering-Plough, Merck has wanted to increase its sales in emerging markets from 18% to 25% by 2013.
Nissen博士,这位美国知名的心脏病专家,激烈的反对两个美国大型制药公司默克和先灵葆雅对Vytorin(一种由这两家公司联合研制的重磅炸弹级别的抗胆固醇的处方药)的临床试验所采取的做法。
Dr Nissen, a leading cardiologist, is up in arms over the way Merck and Schering-Plough, two American pharmaceutical giants, have handled a clinical trial of Vytorin, a blockbuster anticholesterol
Nissen博士,这位美国知名的心脏病专家,激烈的反对两个美国大型制药公司默克和先灵葆雅对Vytorin(一种由这两家公司联合研制的重磅炸弹级别的抗胆固醇的处方药)的临床试验所采取的做法。
Dr Nissen, a leading cardiologist, is up in arms over the way Merck and Schering-Plough, two American pharmaceutical giants, have handled a clinical trial of Vytorin, a blockbuster anticholesterol
应用推荐